Susquehanna International Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10K Buy
41,785
+24,441
+141% +$5.86K ﹤0.01% 6200
2025
Q1
$3.42K Sell
17,344
-11,806
-41% -$2.33K ﹤0.01% 6267
2024
Q4
$15.7K Sell
29,150
-160,322
-85% -$86.4K ﹤0.01% 6017
2024
Q3
$180K Sell
189,472
-52,672
-22% -$50.1K ﹤0.01% 4869
2024
Q2
$236K Buy
242,144
+185,806
+330% +$181K ﹤0.01% 4522
2024
Q1
$89K Sell
56,338
-508
-0.9% -$803 ﹤0.01% 5040
2023
Q4
$45.1K Sell
56,846
-110,042
-66% -$87.3K ﹤0.01% 5560
2023
Q3
$130K Sell
166,888
-14,712
-8% -$11.5K ﹤0.01% 4804
2023
Q2
$168K Buy
+181,600
New +$168K ﹤0.01% 4740
2023
Q1
Sell
-28,126
Closed -$41.1K 5933
2022
Q4
$41.1K Buy
+28,126
New +$41.1K ﹤0.01% 5215
2022
Q3
Sell
-134,912
Closed -$229K 6063
2022
Q2
$229K Buy
134,912
+54,805
+68% +$93K ﹤0.01% 4374
2022
Q1
$165K Sell
80,107
-31,981
-29% -$65.9K ﹤0.01% 4934
2021
Q4
$420K Sell
112,088
-111,326
-50% -$417K ﹤0.01% 4033
2021
Q3
$1.16M Buy
223,414
+113,204
+103% +$585K ﹤0.01% 2593
2021
Q2
$469K Buy
110,210
+59,166
+116% +$252K ﹤0.01% 3966
2021
Q1
$271K Sell
51,044
-96,757
-65% -$514K ﹤0.01% 4460
2020
Q4
$796K Buy
+147,801
New +$796K ﹤0.01% 2858
2020
Q3
Hold
0
4372
2020
Q2
Hold
0
4197
2018
Q4
Sell
-64,763
Closed -$878K 3575
2018
Q3
$878K Buy
+64,763
New +$878K ﹤0.01% 1562
2018
Q2
Sell
-54,405
Closed -$611K 3578
2018
Q1
$611K Buy
+54,405
New +$611K ﹤0.01% 1923
2017
Q4
Hold
0
3607
2017
Q3
Hold
0
3098
2017
Q1
Sell
-15,941
Closed -$65K 3195
2016
Q4
$65K Buy
+15,941
New +$65K ﹤0.01% 3949
2016
Q1
Sell
-10,844
Closed -$131K 3803
2015
Q4
$131K Buy
+10,844
New +$131K ﹤0.01% 3886